Stoke Therapeutics Inc (STOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,885 | -88,981 | -104,699 | -101,067 | -85,805 |
| Depreciation Amortization | 637 | 535 | 2,144 | 1,335 | 1,117 |
| Accounts receivable | -4,268 | -50 | N/A | N/A | N/A |
| Other Working Capital | 16,346 | -28,140 | -6,030 | 43,023 | 46 |
| Other Operating Activity | 39,755 | 29,785 | 27,518 | 24,843 | 17,735 |
| Operating Cash Flow | $45,585 | $-86,851 | $-81,067 | $-31,866 | $-66,907 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -670 | -203 | -1,616 | -3,962 | -1,200 |
| Purchase Of Investment | -322,722 | -167,272 | N/A | -201,320 | -87,226 |
| Sale Of Investment | 136,580 | 60,000 | 107,562 | 159,400 | 12,000 |
| Investing Cash Flow | $-186,812 | $-107,475 | $105,946 | $-45,882 | $-76,426 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 96,387 | 10,678 | 52,452 | 45,838 | 777 |
| Other Financing Activity | 1,002 | 120,416 | 555 | 571 | 507 |
| Financing Cash Flow | $97,389 | $131,094 | $53,007 | $46,409 | $1,284 |
| Beginning Cash Position | 128,779 | 192,011 | 114,125 | 145,464 | 287,513 |
| End Cash Position | 84,941 | 128,779 | 192,011 | 114,125 | 145,464 |
| Net Cash Flow | $-43,838 | $-63,232 | $77,886 | $-31,339 | $-142,049 |
| Free Cash Flow | |||||
| Operating Cash Flow | 45,585 | -86,851 | -81,067 | -31,866 | -66,907 |
| Capital Expenditure | -670 | -203 | -1,616 | -3,962 | -1,200 |
| Free Cash Flow | 44,915 | -87,054 | -82,683 | -35,828 | -68,107 |